Pharma Tech Trends That Are Changing The Drug Development Process

The pharmaceutical industry has been adopting new technology to advance healthcare and meet regulatory affairs requirements. Innovations such as artificial intelligence, virtual screening, and 3D printing are giving pharmaceutical companies efficient ways to support drug discovery, drug delivery, and packaging across the United States and worldwide. The following are some of the top pharma tech trends making a notable impact on healthcare today.

Digital Technology in the Pharmaceutical Industry

1. Artificial Intelligence

Artificial intelligence (AI) is producing major improvements in pharmaceutical manufacturing processes and patient identification. AI supports automation across pharmaceutical development, helping reduce waste and the risk of errors during production.

Where AI is making the biggest impact:

• Drug discovery and design: AI now aids virtual screening of molecular compounds, helping researchers identify viable active pharmaceutical ingredients faster in the early stage of drug development.
• Clinical trial acceleration: In June 2025, Insilico Medicine reported positive Phase 2a results in Nature Medicine for rentosertib, an idiopathic pulmonary fibrosis treatment whose disease target and molecule were both designed using generative AI, reaching preclinical candidate nomination in 18 months instead of the typical 3 to 4 years.
• Patient identification: Machine learning is reducing medication errors during drug administration by improving the accuracy of patient matching.
• Pharmaceutical investment: The widespread adoption of new technology has driven a rise in pharmaceutical investment, as companies build advanced systems into research and manufacturing.

2. Big Data Analysis and Cloud Storage

Pharma companies require large data sets to be analyzed and stored throughout the drug development process. From drug discovery and pre-clinical work to clinical studies and clinical trials, researchers depend on efficient methods to evaluate findings.

Efficient big data analysis supports a continuous developmental process across the pharmaceutical industry. This matters as precision medicine grows, addressing unmet needs by tailoring treatment to genetics, environment, and lifestyle. Pharmaceutical companies and research institutions also rely on cloud computing to securely store sensitive information, giving research teams on-demand access to lab data, medical imaging, and pharmaceutical analysis tools.

3. Blockchain Technology

With the rise in online medication transactions, consumers face a higher risk of receiving counterfeit or substandard drug products. Blockchain technology guards against this through encryption and decentralized databases.

Under the FDA’s Drug Supply Chain Security Act (DSCSA), blockchain is being explored as a traceability solution for tracking the entire life cycle of pharmaceutical products from manufacturer to pharmacy. The added accountability also reinforces product quality and quality control across the supply chain.

4. Real-World Data

Real-world data supports improvements in drug delivery systems, formulation development, and the assessment of medication effectiveness. Researchers also use it to design clinical studies that address unmet needs in chronic disease and rare conditions.

Common sources of real-world data include:

• Electronic health records
• Insurance claims data
• Wearable devices and remote monitoring tools
• Medical device outputs
• Patient registries and disease databases

The U.S. Food and Drug Administration is increasingly relying on real-world evidence to review medication safety and monitor adverse events tied to new drug discoveries.

5. Cybersecurity

Cybersecurity in healthcare and the pharmaceutical industry has become more pressing as security risks grow more complex. Healthcare organizations hold sensitive patient data, which puts them at elevated risk of attack from ransomware, phishing, third-party vendor exposures, and the Internet of Things (IoT).

According to IBM’s 2025 Cost of a Data Breach Report:

• Healthcare remains the costliest industry for breaches for the 14th consecutive year
• The average breach cost is $7.42 million per incident
• Healthcare takes the longest to detect and contain breaches, averaging 279 days

Building cybersecurity controls, training employees, and adopting AI-driven monitoring services give pharmacy and hospital directors stronger ways to protect both patient and pharmaceutical data.

Production Processes

1. Manufacturing to Meet Market Dynamics

Market dynamics in the pharmaceutical industry have shifted in recent years, and technology trends are giving pharmaceutical companies practical ways to keep pace.

Notable shifts in modern pharmaceutical manufacturing:

• Smaller batch production in response to the growth of personalized and precision medicine
• Specialized facilities sized for low-volume rather than high-volume output
• Greater reliance on new technology to support modern product development of high-value dosage forms
• Modular and scalable equipment that can adapt to shifting demand

2. Continuous Manufacturing Process

Pharmaceutical companies look for ways to improve operational efficiency during the manufacturing process. Continuous manufacturing supports a steady flow from pharmaceutical research labs to market.

Advantages of continuous manufacturing include:

• Shorter time-to-market for new pharmaceutical products
• Lower operating costs and reduced environmental footprint
• More consistent product quality and stronger quality assurance
• Lower risk of human error compared to multi-step batch processing
• Closer alignment with current good manufacturing practice expectations

These tools have been adopted in small-molecule drug facilities and bioprocessing, supporting steady output across the pharmaceutical industry.

3. Advanced 3D Printing of Human Tissue

The use of 3D printing has grown across healthcare. Research into bioprinted human tissue continues at universities, research institutions, and contract testing laboratories, with the goal of producing tissue for organ transplants and improving preclinical drug testing.

The pharmaceutical science community sees 3D bioprinting as a potentially safer alternative to early-stage clinical trials that rely on human volunteers. While the technology has not yet replaced human participants in clinical studies, continued research, much of it shared through open access publications and supported by university master’s programme partnerships, is moving the field closer to broader adoption.

4. Growth in CDMO Market

The contract development and manufacturing organization (CDMO) sector continues to expand. The global healthcare CDMO market is projected to reach $648 billion by 2033, growing at a 10.08% CAGR, fueled by rising outsourcing and growing R&D demand. CDMOs handle drug formulation development and manufacturing rather than producing pre-formulated medications like traditional CMOs.

What CDMOs typically provide:

• Drug formulation development and scale-up
• Active pharmaceutical ingredient (API) manufacturing
• Raw material sourcing and supply chain support
• Clinical testing services
• Regulatory affairs support for drug approvals

In response to mounting speed-to-market pressure, CDMOs are forming strong partnerships with pharmaceutical companies to help medications reach patients faster.

MPI Offers State-of-the-Art Solutions for Medication Packaging

Medical Packaging Inc., LLC (MPI) is an industry leader in unit dose packaging and labeling systems backed by decades of hands-on experience supporting pharmacy and hospital directors. Our packaging solutions are tailored to each customer’s workflow, helping reduce medication errors and protect patient safety. We serve specialty pharmaceutical manufacturers and contract drug manufacturing organizations with liquid cup unit dosage form systems that deliver high-quality, FDA-compliant packages at a low price point.

With our FDA-accepted Type III Drug Master File, MPI provides speed-to-market regulatory and technical support for medical and pharmaceutical market clients. Contact us to learn more about how our products and services can support your packaging operation.